Home LiteratureArticle Details
PMID: 14504135 Published · ppublish English Journal Article Review

Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells.

British journal of pharmacology ·Vol. 140 ·No. 4 ·2003-10-00 ·Pages 595-610

Gerritsen ME, Tomlinson JE, Zlot C, Ziman M, Hwang S

Abstract

Hepatocyte growth factor (HGF) and vascular endothelial cell growth factor (VEGF) are two potent endothelial mitogens with demonstrated angiogenic activities in animal models of therapeutic angiogenesis. Several recent studies suggest that these growth factors may act synergistically, although the mechanism of this interaction is not understood. Changes in the gene expression profile of human umbilical vein endothelial cells treated with HGF, VEGF or the combination of the two were analyzed with high-density oligonucleotide arrays, representing approximately 22000 genes. Notably, the genes significantly up- and downregulated by VEGF versus HGF exhibited very little overlap, indicating distinct signal transduction pathways. The combination of HGF and VEGF markedly increased the number of significantly up- and downregulated genes. At 4 h, the combination of the two growth factors induced a number of chemokine and cytokines and their receptors (IL-8, IL-6, IL-11, CCR6, CXCR1,CXC1 and IL17RC), numerous genes involved in growth factor signal transduction (egr-1, fosB, grb10, grb14,MAP2K3,MAP3K8, MAPKAP2,MPK3, DUSP4 and DUSP6), as well as a number of other growth factors (PDGFA, BMP2, Hb-EGF, FGF16, heuregulin beta 1, c-kit ligand, angiopoietin 2 and angiopoietin 4 and VEGFC). In addition, the VEGF receptors neuropilin-1 and flt-1 were also upregulated. At 24 h, a clear 'cell cycle' signature is noted, with the upregulated expression of various cell cycle control proteins and gene involved in the regulation of mitosis and mitotic spindle assembly. The receptor for HGF, c-met, is also upregulated. These data are consistent with the hypothesis that the combination of HGF and VEGF results in the cooperative upregulation of a number of different molecular pathways leading to a more robust proliferative response, that is, growth factor(s), receptors, molecules involved in growth factor signal transduction, as well as, at later time points, upregulation of the necessary cellular proteins required for cells to escape cell cycle arrest and enter the cell cycle.

MeSH Terms
Endothelial Cells/metabolism Gene Expression Profiling/methods Hepatocyte Growth Factor/chemistry,genetics,metabolism Humans Molecular Probes/chemistry Oligonucleotide Array Sequence Analysis/methods Vascular Endothelial Growth Factors/chemistry,genetics,metabolism
Chemicals
Molecular Probes Vascular Endothelial Growth Factors Hepatocyte Growth Factor
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Gerritsen Mary E
Department of Vascular Biology, Millennium Pharmaceuticals, South San Francisco, CA 94080, USA. meg570@comcast.net
Tomlinson James E
Zlot Constance
Ziman Michael
Hwang Stuart
References (51)
51 references, click to expand
  1. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells.
    Circulation. 1999 Nov 9;100(19 Suppl):II301-8 PMID: 10567320
  2. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells.
    J Cell Physiol. 1999 Nov;181(2):319-29 PMID: 10497311
  3. The biology of stem cell factor and its receptor C-kit.
    Int J Biochem Cell Biol. 1999 Oct;31(10):1037-51 PMID: 10582338
  4. bFGF increases collateral blood flow in aged rats with femoral artery ligation.
    Am J Physiol Heart Circ Physiol. 2000 Jan;278(1):H85-93 PMID: 10644587
  5. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles.
    Science. 2000 Feb 4;287(5454):873-80 PMID: 10657304
  6. Gene expression profiling in an in vitro model of angiogenesis.
    Am J Pathol. 2000 Jun;156(6):1887-900 PMID: 10854212
  7. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway.
    Oncogene. 2000 Sep 14;19(39):4549-52 PMID: 11002428
  8. The role of IL-II in hematopoiesis as revealed by a targeted mutation of its receptor.
    Stem Cells. 1998;16 Suppl 2:53-65 PMID: 11012177
  9. The role of recombinant interleukin 11 in megakaryocytopoiesis.
    Stem Cells. 1996;14 Suppl 1:53-61 PMID: 11012203
  10. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial.
    J Am Coll Cardiol. 2000 Oct;36(4):1239-44 PMID: 11028477
  11. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model.
    J Surg Res. 2000 Oct;93(2):219-29 PMID: 11027464
  12. Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system.
    Br J Haematol. 2001 Feb;112(2):397-404 PMID: 11167838
  13. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.
    Am J Pathol. 2001 Mar;158(3):1111-20 PMID: 11238059
  14. Role of stem cell factor and c-kit signaling in regulation of fetal intestinal epithelial cell adhesion to fibronectin.
    Exp Cell Res. 2001 Jun 10;266(2):311-22 PMID: 11399059
  15. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling.
    J Cell Sci. 2001 Aug;114(Pt 15):2755-73 PMID: 11683410
  16. Stem cell factor: laboratory and clinical aspects.
    Blood Rev. 2001 Dec;15(4):191-7 PMID: 11792120
  17. Feature extraction and normalization algorithms for high-density oligonucleotide gene expression array data.
    J Cell Biochem Suppl. 2001;Suppl 37:120-5 PMID: 11842437
  18. [Cloning of a novel gene, ANGPTL4 and the functional study in angiogenesis].
    Zhonghua Yi Xue Za Zhi. 2002 Jan 25;82(2):94-9 PMID: 11953136
  19. In silico data filtering to identify new angiogenesis targets from a large in vitro gene profiling data set.
    Physiol Genomics. 2002 Jul 12;10(1):13-20 PMID: 12118101
  20. The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): molecular basis and clinical relevance.
    Leuk Lymphoma. 2002 Jun;43(6):1179-87 PMID: 12152985
  21. Hepatocyte growth factor upregulates thymosin beta4 in human umbilical vein endothelial cells.
    Biochem Biophys Res Commun. 2002 Aug 16;296(2):401-5 PMID: 12163032
  22. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells.
    Angiogenesis. 2001;4(4):289-98 PMID: 12197474
  23. Dual role of Ang2 in postnatal angiogenesis and lymphangiogenesis.
    Dev Cell. 2002 Sep;3(3):302-4 PMID: 12361591
  24. Ex vivo expansion of hematopoietic stem cells by cytokines.
    Biochim Biophys Acta. 2002 Nov 11;1592(3):313-21 PMID: 12421675
  25. Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors.
    Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1797-803 PMID: 12426207
  26. Effects of interleukin-11 on the hematopoietic action of granulocyte colony-stimulating factor.
    Arzneimittelforschung. 2002;52(11):857-61 PMID: 12489258
  27. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
    Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):69-75 PMID: 12524227
  28. Therapeutic angiogenesis: protein-based therapy for coronary artery disease.
    Expert Opin Pharmacother. 2003 Feb;4(2):219-26 PMID: 12562312
  29. Branching out: a molecular fingerprint of endothelial differentiation into tube-like structures generated by Affymetrix oligonucleotide arrays.
    Microcirculation. 2003 Jan;10(1):63-81 PMID: 12610664
  30. The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
    Circulation. 2003 Mar 18;107(10):1359-65 PMID: 12642354
  31. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1.
    Circulation. 2003 Mar 18;107(10):1411-7 PMID: 12642363
  32. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Cancer Res. 2003 Apr 1;63(7):1576-82 PMID: 12670907
  33. Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology.
    J Nephrol. 2003 Mar-Apr;16(2):168-78 PMID: 12768063
  34. Hepatocyte growth factor modulates migration and proliferation of human microvascular endothelial cells in culture.
    Biochem Biophys Res Commun. 1991 Sep 16;179(2):1042-9 PMID: 1654897
  35. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor.
    J Vasc Surg. 1992 Aug;16(2):181-91 PMID: 1379646
  36. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.
    J Cell Biol. 1992 Nov;119(3):629-41 PMID: 1383237
  37. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro.
    Biochem Biophys Res Commun. 1992 Dec 15;189(2):824-31 PMID: 1281999
  38. The development and enhancement of the collateral circulation in an animal model of lower limb ischaemia.
    Aust N Z J Surg. 1994 Mar;64(3):202-7 PMID: 8117201
  39. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.
    Circulation. 1995 Nov 1;92(9 Suppl):II365-71 PMID: 7586439
  40. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor.
    J Hypertens. 1996 Sep;14(9):1067-72 PMID: 8986905
  41. The c-kit receptor is involved in the adhesion of mouse primordial germ cells to somatic cells in culture.
    Mech Dev. 1997 Nov;68(1-2):37-44 PMID: 9431802
  42. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis.
    Circulation. 1998 Feb 3;97(4):381-90 PMID: 9468212
  43. HGF/SF in angiogenesis.
    Ciba Found Symp. 1997;212:215-26; discussion 227-9 PMID: 9524773
  44. Stem cell factor enhances the adhesion of AML cells to fibronectin and augments fibronectin-mediated anti-apoptotic and proliferative signals.
    Leukemia. 1998 Sep;12(9):1375-82 PMID: 9737685
  45. Basic fibroblast growth factor stimulates angiogenesis in the hindlimb of hyperglycemic rats.
    J Surg Res. 1998 Sep;79(1):8-12 PMID: 9735233
  46. Regulation of new blood vessel growth into ischemic skeletal muscle.
    J Vasc Surg. 1998 Nov;28(5):919-28 PMID: 9808862
  47. Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF).
    Vasa. 1998 Nov;27(4):201-6 PMID: 9859738
  48. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells.
    Lab Invest. 1999 Apr;79(4):427-38 PMID: 10211995
  49. The potential role of stem cell factor and its receptor c-kit in the mouse blastocyst implantation.
    Mol Hum Reprod. 1999 Sep;5(9):874-9 PMID: 10460227
  50. Role of vascular endothelial growth factor in the regulation of angiogenesis.
    Kidney Int. 1999 Sep;56(3):794-814 PMID: 10469350
  51. Clinical applications of angiogenic growth factors and their inhibitors.
    Nat Med. 1999 Dec;5(12):1359-64 PMID: 10581076
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
2003-10-00
Epub
2003-00-22
Pages
595-610
Language
English
Region
England
NLM ID
7502536
PMCID
PMC1574080
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com